About the job
Revolution Medicines is a pioneering clinical-stage precision oncology firm dedicated to the advancement of innovative targeted therapies aimed at inhibiting novel targets in RAS-addicted cancers. Our robust R&D pipeline includes the development of RAS(ON) Inhibitors designed to suppress various oncogenic RAS protein variants, alongside RAS Companion Inhibitors that facilitate combination treatment strategies. As a key member of the Revolution Medicines team, you will collaborate with other dedicated professionals in our unwavering commitment to supporting patients battling cancers with mutations in the RAS signaling pathway.
The Opportunity:
In this role, you will act as the lead statistician for oncology studies, coordinating with various functional teams to ensure the timely delivery of project milestones.
Represent biostatistics on study/project teams.
Provide expert statistical input for the design, analysis, and reporting of clinical studies.
Collaborate with cross-functional teams on study design, protocol development, statistical methodologies, and analyses.
Craft statistical analysis plans and specification documents.
Work closely with statistical programming to confirm analyses adhere to established plans and specifications.
Partner with data management and clinical operations to facilitate the development of robust case report forms (CRF) and ensure high-quality data collection.
Engage in publications, assist with data interpretation, and guarantee the consistency and accuracy of data presentations.
Stay updated on the latest developments in statistics, drug development, and regulatory guidelines, sharing insights with team members.

